Media News

The GlycoMark® Test is More Accurate than HbA1c and Glucose for Predicting Mortality in Diabetic and Non-Diabetic COVID-19 Patients

Study Data Highlighted At 2021 American Heart Association Scientific Sessions RALEIGH, N.C., Nov. 16, 2021 /PRNewswire/ -- Precision Diabetes, Inc. today announces the presentation of data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabetes tests, hemoglobin A1c (HbA1c) and glucose, in predicting mortality in hospitalized...

Molecular Stethoscope, Inc. Announces Presentation of Primary Sclerosing Cholangitis (PSC) Study at the AASLD Liver Meeting 2021

Study results demonstrate the utility of the Company's Next-Generation cf-mRNA Liquid Biopsy Technology Platform for the characterization of PSC PALO ALTO, Calif., Nov. 16, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology company, announces presentation of its human proof-of-concept study applying its proprietary cf-mRNA Liquid Biopsy Technology Platform for the study of Primary Sclerosing Cholangitis (PSC)...

Zepp Health Corporation Reports Third Quarter 2021 Unaudited Financial Results

BEIJING, Nov. 16, 2021 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenue of RMB1.6 billion (US$249.3 million); GAAP diluted net income per share of RMB0.19 (US$0.03); and GAAP diluted net income per ADS of RMB0.74 (US$0.11) for the third quarter ended September 30, 2021. Each ADS represents four (4) Class A ordinary...

US Clinicals(R) Launches the 1st Respiratory Virus Defending Health Supplement in Singapore

SINGAPORE, Nov. 16, 2021 /PRNewswire/ -- US Clinicals®, an award-winning health supplement brand, just announced the launch of their new product, StrongImmune Lactoferrin, which will be available starting 15th November 2021. More than just the average immune booster, StrongImmune Lactoferrin provides dual action immunity support against Acute Respiratory Infection (ARI) to ensure consumers' health and safety during the current...

Baxter Indonesia launches My Kidney Journey portal to support patients with Chronic Kidney Disease

JAKARTA, Indonesia, Nov. 16, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch of My Kidney Journey (www.infoginjal.com), a comprehensive online portal to support patients living with Chronic Kidney Disease (CKD) in Indonesia. Chronic Kidney Disease (CKD) is on the rise in APAC and continues to be a major public health...

Advanced Sterilization Products’ Global Commercial Leader, Nilesh Shah, sets sights on preventing HAIs in Asia

SINGAPORE, Nov. 16, 2021 /PRNewswire/ -- Advanced Sterilization Products' (ASP) recently appointed Vice President, General Manager and Global Commercial Leader, Nilesh Shah looks to strengthen ASP's footing in growing markets to improve healthcare standards by reducing the rate of healthcare-associated infections (HAI). Nilesh Shah - VP/GM Global Commercial, Advanced Sterilization Products...

Baxter Philippines launches My Kidney Journey portal to support patients with Chronic Kidney Disease

MANILA, Philippines, Nov. 16, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch of My Kidney Journey, a comprehensive online portal to support patients living with Chronic Kidney Disease (CKD) in the Philippines. Chronic Kidney Disease (CKD) is on the rise in APAC and continues to be a major public health problem....

Baxter Brunei launches My Kidney Journey portal to support patients with Chronic Kidney Disease

BANDAR SERI BEGAWAN, Brunei, Nov. 16, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch of My Kidney Journey, a comprehensive online portal to support patients living with Chronic Kidney Disease (CKD) in Brunei. Chronic Kidney Disease (CKD) is on the rise in APAC and continues to be a major public health problem. It...

Baxter Healthcare launches My Kidney Journey portal to support patients with Chronic Kidney Disease in Asia Pacific

SINGAPORE, Nov. 16, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch of My Kidney Journey, a comprehensive online portal to support patients living with Chronic Kidney Disease (CKD) in the Asia Pacific (APAC) region. Chronic Kidney Disease (CKD) is on the rise in APAC and continues to be a...

Clinical Studies of PD-L1 Antibody ASC22 for HBV Functional Cure Selected for Inclusion in the “Best of The Liver Meeting’s Summary” by AASLD Review Committee

-- Inclusion in the "Best of The Liver Meeting's Summary" is a singular honor and indicates the high level with which the AASLD review committee regards Ascletis' research in CHB -- In patients with the baseline HBsAg level ≤ 500 IU/mL, the Phase IIb study demonstrated sustained HBsAg loss in 19% patients in the treatment group vs no subject achieved HBsAg...